Back to Journals » Drug Design, Development and Therapy » Volume 4

Drug Design, Development and Therapy


Archive: Volume 4, 2010

Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets

Suhas S Khandave, Satish V Sawant, Santosh S Joshi, et al

Drug Design, Development and Therapy 2010, 4:367-374

Published Date: 25 November 2010

New approaches in the management of multiple sclerosis

Laurie J Barten, Douglas R Allington, Kendra A Procacci, et al

Drug Design, Development and Therapy 2010, 4:343-366

Published Date: 24 November 2010

Silodosin in the treatment of benign prostatic hyperplasia

Maxime Rossi, Thierry Roumeguère

Drug Design, Development and Therapy 2010, 4:291-297

Published Date: 27 October 2010

Liraglutide in the management of type 2 diabetes

Estela Wajcberg, Amatur Amarah

Drug Design, Development and Therapy 2010, 4:279-290

Published Date: 22 October 2010

Thermosensitive Pluronic® hydrogel: prolonged injectable formulation for drug abuse

Katayoun Derakhshandeh, Mahtab Fashi, Seyedalireza Seifoleslami

Drug Design, Development and Therapy 2010, 4:255-262

Published Date: 20 September 2010

Chimeric design, synthesis, and biological assays of a new nonpeptide insulin-mimetic vanadium compound to inhibit protein tyrosine phosphatase 1B

Thomas Scior, José Antonio Guevara-García, FJ Melendez, et al

Drug Design, Development and Therapy 2010, 4:231-242

Published Date: 23 September 2010

Safety and efficacy of azacitidine in myelodysplastic syndromes

Carlos E Vigil, Taida Martin-Santos, Guillermo Garcia-Manero

Drug Design, Development and Therapy 2010, 4:221-229

Published Date: 9 September 2010

Antithrombotic strategies in patients undergoing percutaneous coronary intervention for acute coronary syndrome

Son V Pham, Phuong-Chi T Pham, Phuong-Mai T Pham, et al.

Drug Design, Development and Therapy 2010, 4:203-220

Published Date: 6 September 2010

Emerging treatments in the management of schizophrenia – focus on sertindole

Maria Rosaria A Muscatello, Antonio Bruno, Gianluca Pandolfo, et al

Drug Design, Development and Therapy 2010, 4:187-201

Published Date: 24 August 2010

Development of QSAR model for immunomodulatory activity of natural coumarinolignoids

Dharmendra K Yadav, Abha Meena, Ankit Srivastava, et al

Drug Design, Development and Therapy 2010, 4:173-186

Published Date: 30 July 2010

A once-daily dose of tadalafil for erectile dysfunction: compliance and efficacy

Samuel L Washington III, Alan W Shindel

Drug Design, Development and Therapy 2010, 4:159-171

Published Date: 4 August 2010

Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

Mark A Giembycz, Stephen K Field

Drug Design, Development and Therapy 2010, 4:147-158

Published Date: 14 July 2010

Identification of targets and new developments in the treatment of multiple sclerosis – focus on cladribine

Clemens Warnke, Heinz Wiendl, Hans-Peter Hartung, et al

Drug Design, Development and Therapy 2010, 4:117-126

Published Date: 18 June 2010

Development of a sublingual allergy vaccine for grass pollinosis

Franco Frati, Silvia Scurati, Paola Puccinelli, et al

Drug Design, Development and Therapy 2010, 4:99-105

Published Date: 17 June 2010

Emerging role of gefitinib in the treatment of non-small-cell lung cancer (NSCLC)

M Tiseo, M Bartolotti, F Gelsomino, et al

Drug Design, Development and Therapy 2010, 4:81-98

Published Date: 19 May 2010

ACAM2000™: The new smallpox vaccine for United States Strategic National Stockpile

Aysegul Nalca, Elizabeth E Zumbrun

Drug Design, Development and Therapy 2010, 4:71-79

Published Date: 17 May 2010

New anticoagulants for the prevention of venous thromboembolism

Cecilia Becattini, Alessandra Lignani, Giancarlo Agnelli

Drug Design, Development and Therapy 2010, 4:49-60

Published Date: 7 April 2010

New atypical antipsychotics for schizophrenia: iloperidone

Silvio Caccia, Luca Pasina, Alessandro Nobili

Drug Design, Development and Therapy 2010, 4:33-48

Published Date: 15 February 2010

Continuation treatment of major depressive disorder: is there a case for duloxetine?

Trevor R Norman, James S Olver

Drug Design, Development and Therapy 2010, 4:19-31

Published Date: 12 February 2010

Corrigendum

Nusrat Motlekar, Bi-Botti Youan

Drug Design, Development and Therapy 2010, 4:7-8

Published Date: 26 January 2010

Recent advances in the treatment of premature ejaculation

Kate D Linton, Kevan R Wylie

Drug Design, Development and Therapy 2010, 4:1-6

Published Date: 5 January 2010